Louisiana woman files lawsuit claiming Padaxa caused internal bleeding
NEW ORLEANS - Claiming she suffered from internal bleeding after ingesting the prescription drug Padaxa, a Louisiana woman has filed a lawsuit against the drug manufacturers for not warning of the drug's side effects.
Thelma Hawthorne filed suit against Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GMBH & Co. KG, Boehringer Ingelheim International GMBH, Bidachem S.P.A. on May 11 in federal court in New Orleans.
The plaintiff states that she suffered severe internal bleeding after ingesting Pradaxa. The drug was approved by the FDA in October of 2010 for the prevention of stroke in patients with non-valvular atrial fibrillation.
The defendants are accused of selling, distributing and manufacturing the "defective and unreasonably dangerous drug." Hawthorne argues that the drug was defectively designed, inadequately tested, dangerous to human health, and lacked proper warnings.
The plaintiff is asking the court for an award of damages for disfigurement, conscious pain, suffering, mental anguish, mental suffering, embarrassment, shame, loss of enjoyment of life, loss of association, loss of earnings, loss of profits, loss of salary, medical expenses, mental and physical impairment, lost wages, interest, and court costs.
Hawthorne is represented by Robert L. Salim of Salim-Beasley in Natchitoches. A jury trial is requested.
U.S. District Judge Jay C. Zainey is assigned to the case.
Case No. 2:12-cv-01203